trending Market Intelligence /marketintelligence/en/news-insights/trending/f2AW7wLbpmfYCq3Ii_0TcQ2 content esgSubNav
In This List

Aphria closes acquisition of Germany's CC Pharma

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Aphria closes acquisition of Germany's CC Pharma

Canadian cannabis company Aphria Inc. completed its previously announced acquisition of Germany-based pharmaceutical distributor CC Pharma GmbH.

Upon closing, former CC Pharma shareholders were paid with €18.9 million cash. They may also receive up to €23.5 million after closing if certain performance milestones are met.

The acquisition is part of Aphria's expansion efforts in Germany and to ultimately establish a pan-European platform incorporating demand, supply and distribution.